Insmed reported $7.56M in Interest Expense on Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US $ 672K 82K
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Alimera Sciences ALIM:US $ 1.34M 0.11M
Arena Pharmaceuticals ARNA:US $ 1.07M 0.02M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Cytokinetics CYTK:US $ 3.99M 0.03M
Dynavax Technologies DVAX:US $ 4.71M 0.09M
Flexion Therapeutics FLXN:US $ 5.19M 10K
Gilead Sciences GILD:US $ 257M 10M
Insmed INSM:US $ 7.56M 9.03M
Novartis NVS:US $ 201M 1M
Regeneron Pharmaceuticals REGN:US $ 14.6M 0.2M
Sarepta Therapeutics SRPT:US $ 15.65M 3.08M
Vertex Pharmaceuticals VRTX:US $ 15.68M 0.61M